Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Genprex Inc
GNPX | US
2.01
USD-0.01
-0.50%
GNPX | US
About Genprex Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
18/03/2026
Close
2.01
Open
2.07
High
2.08
Low
1.98
Genprex Inc. a clinical-stage gene therapy company focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes and GPX-003 for the treatment of type 2 diabetes. Genprex Inc. was incorporated in 2009 and is headquartered in Austin Texas.
View LessGNPX | US
Risk
116.5
Sharpe
-0.34
Luna's Score
42/100
Recommendation
Sell
Luna says (GNPX | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
38.5%1 month
116.5%3 months
119.9%6 months
366.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.25
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.18
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-26.28M
MarketCap
5.20M
MarketCap(USD)
5.20M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-318.88
Short ratio
0.09
Short perc.
3.16
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.30
Range1M
0.86
Range3M
1.85
Volumes: Market Activity
Rel. volume
0.68
Price X volume
1.54M
